Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1987 1
2003 3
2004 2
2006 3
2007 2
2008 7
2009 5
2010 1
2011 1
2012 2
2013 1
2014 3
2016 1
2018 1
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Results by year
Filters applied: . Clear all
Page 1
TNF-alpha inhibition for potential therapeutic modulation of SARS coronavirus infection.
Tobinick E. Tobinick E. Curr Med Res Opin. 2004 Jan;20(1):39-40. doi: 10.1185/030079903125002757. Curr Med Res Opin. 2004. PMID: 14741070 No abstract available.
Perispinal etanercept advances as a neurotherapeutic.
Tobinick E. Tobinick E. Expert Rev Neurother. 2018 Jun;18(6):453-455. doi: 10.1080/14737175.2018.1468253. Epub 2018 Apr 25. Expert Rev Neurother. 2018. PMID: 29695205 No abstract available.
Perispinal etanercept: potential as an Alzheimer therapeutic.
Griffin WS. Griffin WS. J Neuroinflammation. 2008 Jan 10;5:3. doi: 10.1186/1742-2094-5-3. J Neuroinflammation. 2008. PMID: 18186919 Free PMC article.
An example of this rapid improvement is presented in this issue as a case report by Tobinick and Gross. Such rapid gain of function inspires speculation about the role of gliotransmission or other equally rapid synaptic events in the relationship of TNF to Alzheimer-impact …
An example of this rapid improvement is presented in this issue as a case report by Tobinick and Gross. Such rapid gain of function i …
Perispinal Delivery of CNS Drugs.
Tobinick EL. Tobinick EL. CNS Drugs. 2016 Jun;30(6):469-80. doi: 10.1007/s40263-016-0339-2. CNS Drugs. 2016. PMID: 27120182 Free PMC article. Review.
Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients.
Tobinick E, Davoodifar S. Tobinick E, et al. Curr Med Res Opin. 2004 Jul;20(7):1075-85. doi: 10.1185/030079903125004286. Curr Med Res Opin. 2004. PMID: 15265252
NOTE: This treatment method is protected by multiple patents awarded to Edward Tobinick MD, including U. S. patents 6 015 557; 6 177 077; 6 419 944; 6 537 549 and Australian patent 758 523....
NOTE: This treatment method is protected by multiple patents awarded to Edward Tobinick MD, including U. S. patents 6 015 557; 6 177 …
Perispinal etanercept for neuroinflammatory disorders.
Tobinick E. Tobinick E. Drug Discov Today. 2009 Feb;14(3-4):168-77. doi: 10.1016/j.drudis.2008.10.005. Epub 2008 Dec 6. Drug Discov Today. 2009. PMID: 19027875 Review.
Perispinal etanercept: a new therapeutic paradigm in neurology.
Tobinick E. Tobinick E. Expert Rev Neurother. 2010 Jun;10(6):985-1002. doi: 10.1586/ern.10.52. Expert Rev Neurother. 2010. PMID: 20518613 Review.
The value of drug repositioning in the current pharmaceutical market.
Tobinick EL. Tobinick EL. Drug News Perspect. 2009 Mar;22(2):119-25. doi: 10.1358/dnp.2009.22.2.1303818. Drug News Perspect. 2009. PMID: 19330170 Review.
Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer's disease.
Tobinick E. Tobinick E. Curr Alzheimer Res. 2012 Jan;9(1):99-109. doi: 10.2174/156720512799015073. Curr Alzheimer Res. 2012. PMID: 22191562 Review.
Perispinal etanercept for treatment of Alzheimer's disease.
Tobinick E. Tobinick E. Curr Alzheimer Res. 2007 Dec;4(5):550-2. doi: 10.2174/156720507783018217. Curr Alzheimer Res. 2007. PMID: 18220520 Review.
35 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback